Events

Loading Events

← Back to Events

VIRTUAL EVENT

December 2020

Global AMR Hub Virtual Conference

December 2, 2020

Translating AMR R&D mapping into policy and action. The Global AMR R&D Hub, through its Dynamic Dashboard, is the global knowledge centre for AMR R&D. The Dynamic Dashboard captures and presents: AMR R&D investments from across the globe and One Health sectors; what new antibacterials are in the pipeline; and what is being done to overcome the challenges hindering the development of, and access to and stewardship of, priority antibacterials. The important next step for the Global AMR R&D Hub…

Find out more »

Infectious Diseases Virtual Partnering

December 2, 2020 - December 4, 2020

Infectious diseases have always impacted human history, but in the past 50 years we have managed to control or eliminate some infectious diseases through improved hygiene, vaccination, antimicrobials, advances in medicine and public health policies. However, the current pandemic is a reminder that we need to continue to pursue our efforts to control these pathogens, especially with intercontinental travel and increased mobility of people and animals. To manage infectious diseases, we use tools such as vaccines, antibiotics, antivirals, diagnostic tools…

Find out more »

2020 ASM Conference on Next-Generation Sequencing

December 7, 2020 - December 11, 2020

Join us at the virtual 2020 ASM Conference on Next-Generation Sequencing, taking place Dec. 7-11, 2020, and get comprehensive guidance with up-to-date examples in the use of NGS technology for applied results in the traceability and clustering of microbial pathogens associated with food safety, clinical infection, environmental contamination and other potential sources of disease outbreaks. You’ll walk away with access to the available resources and direction you need relating to bioinformatics and epidemiology. Click here to learn more. Click here to view…

Find out more »

January 2021

National Academy of Science

January 5, 2021

The National Academy of Sciences (NAS) is a private, nonprofit organization of the country’s leading researchers. The NAS recognizes and promotes outstanding science through election to membership; publication in its journal, PNAS; and its awards, programs, and special activities. Through the National Academies of Sciences, Engineering, and Medicine, the NAS provides objective, science-based advice on critical issues affecting the nation. CARB-X participants include Kevin Outterson, Executive Director. Click here to learn more.

Find out more »

Keystone Symposia: Harnessing the Microbiome for Disease Prevention and Therapy

January 18, 2021 - January 20, 2021

Joint meeting with: The Microbiome: From Mother to Child January 18-20, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET* Our understanding of the microbiome is advancing rapidly, and continues to productively move through the discovery phase, with numerous correlations being established between specific commensal microbes or microbiota compositions and a wide range of diseases that includes infections, inflammatory conditions, metabolic disease, autoimmunity and neurologic syndromes. The initial discovery of these potentially important correlations has led many laboratories around the world…

Find out more »

Innovative Medicines Initiative (IMI) ENABLE Annual Meeting

January 21, 2021

Antimicrobial resistance (AMR) is a major public health threat. Infections caused by resistant bacteria are increasing and causing Europe to face soaring costs both in terms of lives and public health expenditure. Despite the strong need for new antimicrobials, very few new, effective antibiotics have been brought to the market in the last decades. The ENABLE project, within IMI’s New Drugs for Bad Bugs (ND4BB) programme, is working to advance the development of potential antibiotics against Gram-negative bacteria, such as…

Find out more »

4th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference

January 26, 2021 - January 28, 2021

Please make plans to join us for this outstanding line-up of internationally-renowned experts in antimicrobial resistance and stewardship. Click here to learn more. Click here to view the agenda. Click here to register.

Find out more »

February 2021

BSAC/GARDP Antimicrobial Chemotherapy Virtual Conference 2021

February 2, 2021 - February 3, 2021

Jointly organised by the BSAC and GARDP. For 2021, the conference collaborators are the Helmholtz Institute for Pharmaceutical Sciences (HIPS), the German Center for Infection Research (DZIF) and the International Research Alliance for Antibiotic Discovery and Development (IRAADD) (a JPIAMR funded network) Click here to learn more. Click here to register.

Find out more »

C-CAMP AMR Webinar Series: Pre-Clinical and Early Drug Development in India

February 2, 2021 @ 10:00 am - 12:00 pm

India is fast emerging as one of the global hubs for conducting pre- clinical and clinical development. The webinar will showcase the competencies of some of the CROs in India and how Product Developers can leverage the advantages of working with Indian CROs.  Participating CROs include: Bioneeds India Syngene International SIRO Clinpharm Sai Life Sciences GVK Bio Click here to learn more and register. Click here to view the zoom link.

Find out more »

The Bloomsbury SET Conference on Infectious Disease and AMR

February 22, 2021 - February 26, 2021

The Bloomsbury SET is hosting its first virtual conference focused on knowledge exchange and infectious disease during the 22nd to 26th February 2021. Throughout the week, the Bloomsbury SET and wider partners will explore interdisciplinary innovation, research translation, commercialisation, impact and connecting capabilities to tackle global health challenges through knowledge exchange.  Click here to learn more. Click here to view the agenda. Click here to register.

Find out more »

Phage Futures Congress

February 24, 2021 - February 26, 2021

Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond. Discover how you can be at the forefront of the developing phage therapy market. Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment…

Find out more »

March 2021

Live Webinar: GARDP/REVIVE – Learning from COVID-19 to tackle the silent pandemic of antibiotic resistance

March 4, 2021 @ 10:00 am - 11:30 am

The COVID-19 pandemic has brought into sharp focus the impact of pandemics. The novel coronavirus has claimed more than a million lives, trillions of dollars have been lost, expenditures cut and international efforts to achieve the Sustainable Development Goals put in jeopardy. COVID-19 has demonstrated pandemic preparedness requires a global coordinated effort, and no country can do it alone. Strengthening our ability to fight the silent pandemic of drug-resistant infections must also ensure affordable access to vital health tools, including…

Find out more »

BARDA AMR Vaccine Public Workshop: Vaccines against AMR Threats

March 12, 2021 @ 11:00 am - 1:00 pm

Multi-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential to combat the growing crisis.  Every year, 2.8 million American develop a drug resistant infection and 35,000 people die. Globally, MDR infections kill 700,000 each year - current estimates are that MDR organisms will kill more than 10 million a year by 2050 if left unchecked. BARDA supports development and…

Find out more »

3rd Bacteriophage Therapy Summit 2021

March 23, 2021 - March 24, 2021

The 3rd Bacteriophage Therapy Summit returns! With a new looking speaker line-up and never before seen content, we are excited to continue to unite the community to progress fundamental bacteriophage research into clinically-significant products. The overuse of antibiotics had led to the development of multi-resistant bacterial strains, most notably ESKAPE pathogens, rendering the use of antibiotics, which in many scenarios are useless. However, bacteriophages may hold the key in overcoming the global antibiotic resistance crisis. Although the potential use of…

Find out more »

The Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance at Tufts (Levy CIMAR) Monthly Science Meeting: Innovation Solutions to AMR

March 25, 2021 @ 12:00 pm - 1:00 pm

Please join us on Thursday, March 25th, at noon for this month’s Levy CIMAR Science Meeting on “Innovation Solutions to AMR.” We are excited to hear from Kevin Outterson, Esq., Professor of Law at Boston University and Executive Director of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X. CARB-X is a global partnership hosted at BU Law that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the threat of untreatable bacterial infections. CARB-X…

Find out more »

April 2021

SHEA Spring 2021 Conference

April 13, 2021 - April 16, 2021

Who should come to SHEA Spring 2021? SHEA members and non-members of all disciplines relating to Infection Prevention Programs, Antibiotic Stewardship Programs, Public Health, Pharmacy, Occupational Health, Clinical Microbiology, Quality Improvement, and Patient Safety. If you are involved in infection prevention or infection control you need to be at SHEA Spring 2021! Click here to learn more. Click here to view the agenda. Click here to register.

Find out more »

Anti-Infectives Drug Development Summit

April 20, 2021 - April 22, 2021

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some now considering the field as the new ‘Wall Street darling’, especially given the $1 billion launch of the AMR action fund, the Digital Anti-Infectives Drug Development Summit has arrived as…

Find out more »

May 2021

World Vaccine Congress Washington 2021

May 4, 2021 - May 6, 2021

For the past 20 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities. Our event format allows for whole-sector topics, giving an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conference channels over the 3 days, it increases the relevance of the whole event for everyone who attends.…

Find out more »

June 2021

Sepsis Tech & Innovation 2021

June 22, 2021 - June 23, 2021

Following the success of the inaugural Sepsis Alliance Summit in 2020, Sepsis Alliance is proud to announce the inaugural Sepsis Tech & Innovation virtual conference. Engage with the nation’s leading innovators, clinicians, investors, and policymakers to discuss health technology and innovation, and its tremendous potential to reduce the burden of sepsis. Catapulting off of Sepsis Alliance's successful 2020 Sepsis Alliance Summit with more than 4,000 registered attendees, Sepsis Tech and Innovation is a very exciting opportunity for Sepsis Alliance to…

Find out more »

8th International Human Microbiome Congress (IHMC 2020)

June 27, 2021 - June 29, 2021

In June 2021, the 8th International Human Microbiome Consortium Meeting will include a fully digital format. By doing this we can ensure compliance of healthy and safety measures, and we can guarantee participation from our delegates. With the support of the IHMC board, a strong local Organizing Committee and a Scientific Committee composed of the most renowned scientists and researchers in the Microbiota field, the Congress expects to attract a large international audience of over 1,000 delegates. The program will…

Find out more »

ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance

June 29, 2021 - June 30, 2021

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists, researchers and research…

Find out more »

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Public Meeting

June 29, 2021 - June 30, 2021

The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria. At the June 29-30, 2021 Virtual Public Meeting, the PACCARB will deliberate and vote on two reports to transmit to the Secretary of Health and Human Services, the first from the Disparities in Antibiotics Access and Use Working Group, and the second from…

Find out more »

July 2021

Advances in Antimicrobial Innovation Scientific meeting

July 5, 2021 @ 8:00 am - 12:00 pm

This Royal Society conference will bring together scientists, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances. Anti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades. As therapeutics in current use become less effective, new approaches are required. This event aims to raise awareness and interest for…

Find out more »

Innovations for Tackling Tuberculosis in the Time of COVID-19: A Two-Part Virtual Workshop

July 22, 2021 @ 11:00 am - 1:00 pm

Register now: Innovations for Tackling Tuberculosis in the Time of COVID-19: Part One of a Two-Part Workshop (July 22, 11 AM – 1 PM ET) This public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO End TB Strategy for 2030 and affirmed by the United Nations High-Level Meeting on the Fight Against Tuberculosis. The workshop will feature presentations and discussions that will consider…

Find out more »

August 2021

BIOCOM 5th AMR Conference 2021 ­– Summer Edition: AMR Briefing Sessions

August 24, 2021 @ 8:00 am - August 26, 2021 @ 5:00 pm

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer…

Find out more »

Public Workshop: Science and Regulation of Bacteriophage Therapy

August 30, 2021 - September 1, 2021

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy. Click here to learn more. Click here to view the agenda. Click here to register.

Find out more »

September 2021

BLUE KNIGHT™ Webinar: Antimicrobial Resistance – Breakthrough Innovation and Breaking Barriers

September 15, 2021 @ 10:00 am - 11:00 am

As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge. Johnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new antibiotics being developed to address the AMR challenge? What other innovations might help without increasing antibiotic resistance? Join the discussion as thought leaders share their…

Find out more »

The Vaccines Against Shigella and ETEC (VASE) Conference

September 28, 2021 - September 30, 2021

This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines, hosted by PATH, a global nonprofit dedicated to achieving health equity. Registration is now open for the VASE Virtual Symposium, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual event will provide key updates on vaccines being developed for Shigella, (ETEC) and other emerging diarrheal pathogens, such as non-typhoidal Salmonella. Click here to learn more.

Find out more »

October 2021

Vaccinology in Africa Course 4-15 October 2021 (Online)

October 4, 2021 - October 15, 2021

The course provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and this year's African host, the KEMRI Wellcome Trust Research Programme in Kenya.  These courses alternate between East and West Africa. In 2021, participation is limited to attendants currently working or studying in East Africa.    Applications close 31 August 2021. Click here to learn more.

Find out more »

November 2021

EFPIA – Pandemic Prevention: how Europe can lead the fight against AMR

November 16, 2021 @ 8:00 am - 9:30 am

You’re invited to join this virtual event on Tuesday, 16 November, 2021 at 14:00 - 15:30 CET. The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe, the European…

Find out more »

McGill AMR Innovation Summit

November 19, 2021 @ 2:00 pm - 3:00 pm

Antimicrobials in the era of AMR During World Antimicrobial Awareness Week (Nov. 18-24 2021), the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders. Program 14:00-14:30 Keynote speaker Erin Duffy, PhD (public event) 14:30-15:00 Panel discussion (public event) 15:00-16:00 Industry-Academic networking event (private event) Keynote speaker Erin Duffy, PhD, Chief of R&D, CARB-X CARB-X is a global non-profit…

Find out more »

AMR Industry Alliance Panel on Supporting the Optimal Use of Antimicrobial Medicines through Innovation

November 23, 2021 @ 7:00 am - 8:00 am

This year’s WAAW will take place 18-24 November 2021, with the theme “Spread Awareness, Stop Resistance”. You can read more about WHO’s WAAW campaign here. The AMR Industry Alliance virtual panel session will be organized as short dialogues among experts from the public, private, academic and civil society sectors who will discuss key topics related to the optimal use of antimicrobial medicines as a means of controlling the spread of antimicrobial resistance (AMR). The three short dialogues will focus on the following topics: The…

Find out more »

December 2021

ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

December 8, 2021 - December 9, 2021

The 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place online, Dec. 8-9, 2021.   Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug…

Find out more »

Infection 2021: British Society for Antimicrobial Chemotherapy (BSAC) Winter Conference

December 9, 2021 - December 10, 2021

Join us as we celebrate 50 years of BSAC! Infection 2021 is an exciting two-day hybrid conference looking at the challenges and future of infection management and how we can rise the meet the challenge of antimicrobial resistance. We encourage you to register for either in-person or virtual attendance and submit your abstracts for consideration for oral and poster presentation.  All accepted abstracts will be published in JAC-Antimicrobial Resistance. CARB-X participants include Kevin Outterson, Executive Director, who will be leading…

Find out more »

February 2022

Stewardship can accelerate efforts to combat AMR

February 3 @ 6:00 pm - 7:00 pm

CARB-X Compliance Manager, Rose Garson, will join Taslimarif Saiyed, PhD of Centre for Cellular and Molecular Platforms (C-CAMP) to speak on the role that stewardship and access play in combating #AMR. ✏️ Register: https://bit.ly/3o3op9B

Find out more »

Global Research on Antimicrobial Resistance (GRAM) Virtual Event

February 4 @ 5:00 pm - 6:30 pm

The GRAM report was published in The Lancet on 20 January 2022. The online launch event will explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations; celebrate the global collaboration and 100’s of data partnerships that made this study possible; consider how data can be harnessed to support governments, health systems and civil society to act and reduce the human-cost of AMR; and identify immediate actions that can…

Find out more »

March 2022

The Longitude Prize: AMR& Diagnostic Frontiers: Developing and increasing access to innovative diagnostics in and for low-and-middle-income countries (LMICs)

March 3 @ 2:00 pm - 4:00 pm

Are you developing AMR diagnostics in or for an LMIC? Or do you have a product that could be adapted and tested for use in low resource settings? Pitch your technology and get customer-driven feedback from a panel of global health representatives at the virtual event with FIND, the global alliance for diagnostics and CARB-X. Register to pitch your product. Visit the Longitude Prize website for more information and to sign-up to the event.

Find out more »

June 2022

Public Webinar: How CARB-X Partners are Addressing the Global Health Threat of AMR

June 9 @ 9:00 am - 9:30 am

A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent funding announcement in which BARDA and Wellcome have committed up to an additional US$370 million to CARB-X. Register in advance to attend: https://bostonu.zoom.us/meeting/register/tJcvde6grjIjGNNROqfFhs5d6RSiOirgYin9

Find out more »

Global Vaccine and Immunization Research Forum

June 23 @ 9:00 am - 12:00 pm

Topic: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, Challenges and Future Development Purpose: Antimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections, reducing antibiotic use and reducing pathogen transmission and chances of developing resistance genes. Increasing evidence from observational and modelling studies show the impact of vaccines on AMR. However, this evidence is yet to…

Find out more »

A Grand Bargain for Antimicrobial Procurement: Leveraging Purchasing Systems to Address AMR

June 30 @ 9:00 am - 10:00 am

Join the Center for Global Development for a conversation on new purchasing systems for antimicrobials and the grand bargain stakeholders must strike to govern the global market. This discussion will draw from a new landscape review of antibiotic procurement systems, which synthesized existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system. This research was undertaken as part of CGD’s working group, A Grand Bargain for Antimicrobial Procurement. Speakers will discuss strategies for…

Find out more »

July 2022

Workshop on Generation and Measurement of Vaccine Durability

July 27 @ 12:00 pm - July 28 @ 2:30 pm

Workshop objectives are to 1) review knowledge about vaccine durability; 2) identify factors contributing to vaccine durability; 3) explore assays and markers to measure vaccine durability in people; and 4) identify gaps in the knowledge about vaccine durability requiring further research or funding. NIAID program staff are organizing this workshop along with external experts in vaccinology and immunology.

Find out more »
+ Export Events